Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3031
+0.0121 (4.16%)
At close: Nov 4, 2026, 4:00 PM EST
0.3060
+0.0029 (0.96%)
After-hours: Nov 4, 2026, 7:30 PM EST
Mereo BioPharma Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| - | - | - | - | 0.5 | - | - | - | - | - | 1 | - | 9 | - | - | - | - | - | - | - | |
Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | 0.13 | - | - | - | - | - | -0.27 | -0.24 | 3.43 | -0.35 | -0.36 | -0.38 | -0.21 | -0.23 | -0.16 | -0.15 |
Gross Profit | - | - | - | - | 0.37 | - | - | - | - | - | 1.27 | 0.24 | 5.57 | 0.35 | 0.36 | 0.38 | 0.21 | 0.23 | 0.16 | 0.15 |
Selling, General & Admin | 5.22 | 4.02 | 4.2 | 6.05 | 5.49 | 7.27 | 6.45 | 6.2 | 7.87 | 5.91 | 3.6 | 5.71 | 2.67 | 6.45 | 7.73 | 8.13 | 5.37 | 5.81 | 4.92 | 4.9 |
Research & Development | 1.69 | 4.65 | 3.72 | 3.82 | 4.63 | 3.75 | 8.25 | 2.94 | 4.58 | 3.52 | 4.73 | 3.51 | 3.09 | 4.81 | 5.84 | 6.45 | 8.09 | 8.76 | 9.28 | 9.25 |
Other Operating Expenses | - | - | -0.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | 6.91 | 8.67 | 7.62 | 9.87 | 10.12 | 11.02 | 14.7 | 9.15 | 12.45 | 9.42 | 8.32 | 9.22 | 5.76 | 11.26 | 13.57 | 14.57 | 13.46 | 14.57 | 14.19 | 14.15 |
Operating Income | -6.91 | -8.67 | -7.62 | -9.87 | -9.75 | -11.02 | -14.7 | -9.15 | -12.45 | -9.42 | -7.05 | -8.99 | -0.19 | -10.91 | -13.21 | -14.2 | -13.25 | -14.33 | -14.04 | -14 |
Interest Expense | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 | -0.18 | -0.38 | -0.35 | -0.33 | -0.31 | -0.35 | -0.7 | -1.03 | -0.8 | -1.08 | -1.15 | -1.02 | -1.1 | -1.27 | -1.27 |
Interest & Investment Income | 0.28 | 0.33 | 0.42 | 0.5 | 0.59 | 0.66 | 0.88 | 0.98 | 0.56 | 0.62 | 0.76 | 0.69 | 0.37 | 0.31 | 0.32 | 0.32 | 0.11 | 0.11 | - | - |
Currency Exchange Gain (Loss) | -0.36 | 1.63 | -0.13 | 1.87 | -5.33 | -2.77 | 6.99 | -6.43 | 0.03 | 0.61 | -2.8 | 2.47 | -0.8 | -1.21 | 0.41 | 0.48 | 0.96 | 1.04 | 0.21 | 0.21 |
Other Non Operating Income (Expenses) | 0.01 | 0.02 | -0.01 | 0.5 | -0.1 | 0.42 | 0.16 | -0.06 | -0.07 | -0.45 | -0.2 | - | -0.1 | 0.54 | 4.08 | 4.16 | 1.12 | 1.21 | 17.28 | 17.23 |
EBT Excluding Unusual Items | -7.01 | -6.72 | -7.35 | -7.02 | -14.62 | -12.89 | -7.05 | -15 | -12.26 | -8.95 | -9.64 | -6.53 | -1.75 | -12.08 | -9.48 | -10.39 | -12.09 | -13.07 | 2.18 | 2.18 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.08 | 0.08 |
Pretax Income | -7.01 | -6.72 | -7.35 | -7.02 | -14.62 | -12.89 | -7.05 | -15 | -12.26 | -8.95 | -9.64 | -6.53 | -1.75 | -12.08 | -9.48 | -10.39 | -12.09 | -13.07 | 2.26 | 2.25 |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | -0.53 | - | - | - | 0.08 | 0.05 | -0.45 | -0.48 | 1.83 | 1.82 |
Net Income | -7.01 | -6.72 | -7.35 | -7.02 | -14.62 | -12.89 | -7.05 | -15 | -12.26 | -8.95 | -9.11 | -6.53 | -1.75 | -12.08 | -9.57 | -10.44 | -11.64 | -12.59 | 0.43 | 0.43 |
Net Income to Common | -7.01 | -6.72 | -7.35 | -7.02 | -14.62 | -12.89 | -7.05 | -15 | -12.26 | -8.95 | -9.11 | -6.53 | -1.75 | -12.08 | -9.57 | -10.44 | -11.64 | -12.59 | 0.43 | 0.43 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 161 | 160 | 160 | 160 | 160 | 157 | 155 | 154 | 142 | 140 | 140 | 137 | 126 | 125 | 125 | 125 | 117 | 117 | 112 | 112 |
Shares Outstanding (Diluted) | 161 | 160 | 160 | 160 | 160 | 157 | 155 | 154 | 142 | 140 | 140 | 137 | 126 | 125 | 125 | 125 | 117 | 117 | 114 | 114 |
Shares Change (YoY) | 0.52% | 2.23% | 3.27% | 3.87% | 12.32% | 12.00% | 10.75% | 12.43% | 13.26% | 12.23% | 12.42% | 10.04% | 7.63% | 6.86% | 9.66% | 9.66% | 7.55% | 7.55% | 1.35% | 1.35% |
EPS (Basic) | -0.04 | -0.04 | -0.05 | -0.04 | -0.09 | -0.08 | -0.05 | -0.10 | -0.09 | -0.06 | -0.07 | -0.05 | -0.01 | -0.10 | -0.08 | -0.08 | -0.10 | -0.11 | 0.00 | 0.00 |
EPS (Diluted) | -0.04 | -0.04 | -0.05 | -0.04 | -0.09 | -0.08 | -0.05 | -0.10 | -0.09 | -0.06 | -0.07 | -0.05 | -0.01 | -0.10 | -0.08 | -0.09 | -0.10 | -0.11 | -0.14 | -0.14 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -6.04 | -4.31 | -7.68 | -7.31 | -7.65 | -8.35 | -9.42 | -7.52 | -7.9 | -7.99 | -6.79 | 2.66 | -7.75 | -9.25 | -13.08 | -13.93 | -11.43 | -12.37 | -10.61 | -10.58 |
Free Cash Flow Per Share | -0.04 | -0.03 | -0.05 | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 | -0.06 | -0.06 | -0.05 | 0.02 | -0.06 | -0.07 | -0.10 | -0.11 | -0.10 | -0.11 | -0.09 | -0.09 |
Gross Margin | - | - | - | - | 73.60% | - | - | - | - | - | 127.30% | - | 61.89% | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | -1950.80% | - | - | - | - | - | -705.00% | - | -2.11% | - | - | - | - | - | - | - |
Profit Margin | - | - | - | - | -2923.20% | - | - | - | - | - | -910.90% | - | -19.46% | - | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | -1530.20% | - | - | - | - | - | -678.90% | - | -86.16% | - | - | - | - | - | - | - |
EBITDA | -6.75 | -8.5 | -7.16 | -9.82 | -9.59 | -10.87 | -14.55 | -8.99 | -12.31 | -9.27 | -6.89 | -8.83 | -0.04 | -10.81 | -13.17 | -14.17 | -12.99 | -14.05 | -14 | -13.96 |
EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | -0.48% | - | - | - | - | - | - | - |
D&A For EBITDA | 0.17 | 0.17 | 0.46 | 0.05 | 0.16 | 0.14 | 0.15 | 0.15 | 0.13 | 0.15 | 0.16 | 0.16 | 0.15 | 0.11 | 0.03 | 0.03 | 0.26 | 0.29 | 0.03 | 0.03 |
EBIT | -6.91 | -8.67 | -7.62 | -9.87 | -9.75 | -11.02 | -14.7 | -9.15 | -12.45 | -9.42 | -7.05 | -8.99 | -0.19 | -10.91 | -13.21 | -14.2 | -13.25 | -14.33 | -14.04 | -14 |
EBIT Margin | - | - | - | - | - | - | - | - | - | - | - | - | -2.11% | - | - | - | - | - | - | - |
Effective Tax Rate | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 80.91% | 80.91% |